Medical Writing Writing for Lay Audiences Layperson summaries of clinical trial results: Useful resources in the vacuum of regulatory guidance
mew-150pxjpg

Volume 24, Issue 4 - Writing for Lay Audiences

Layperson summaries of clinical trial results: Useful resources in the vacuum of regulatory guidance

Abstract

To meet the requirements of the clinical trial regulation, preparation for the publication of lay summaries on the European database should be undertaken as soon as possible. However, as of July 2015 (at the time of writing this article), no regulatory guidance has been produced. The main goal of this article is to raise awareness of other resources that writers can use in the interim. This includes templates, guidance, and examples published by the Harvard Workgroup and the Center for Information and Study on Clinical Research Participation, whose work is supported by the EMA and FDA.

Download the full article

References

  1. Sood A, Prasad K, Chhatwani L, Shinozaki E, Cha SS, Loehrer LL, et al. Patients’ attitudes and preferences about participation and recruitment strategies in clinical trials. Mayo Clin Proc. 2009;84(3):243–7. Available from: http://www.mayoclinicproceedings.org/article/S0025-6196(11)61141-5/references
  2. Getz K. Public confidence and trust today. A review of public opinion polls. Monitor. 2008:17–21. Available from: http://www.acrpnet.org//PDF/Monitor/MonitorArchive/Sept2008/11312-05_Getz1.pdf
  3. European Parliament. Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC. OJEU. 2014;L158:1–76. Available from: http://ec.europa.eu/health/files/eudralex/vol-1/reg_2014_536/reg_2014_536_en.pdf
  4. Sroka-Saidi K, Boggetti B, Schindler TM. Transferring regulation into practice: The challenges of the new layperson summary of clinical trial results. EMWA. 2015;24(1):24–27. Available from: http://www.maneyonline.com/doi/abs/10.1179/2047480614Z.000000000274?journalCode=mew
  5. European Parliament. Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. OJEU. 2001;L121:34–44. Available from: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2001:121:0034:0044:en:PDF
  6. ICH. E3 Implementation Working Group. ICH E3 Guideline: Structure and content of clinical study reports questions & answers. 2012 Jun. Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E3/E3_Q_As_Step4.pdf
  7. EPF. EPF position: Clinical trial results – communication of the lay summary. 2015 Mar. Available from: http://www.eu-patient.eu/globalassets/policy/clinicaltrials/epf-lay-summary-position-march-2015.pdf
  8. US Government. FDAAA. Title VIII - Clinical trial databases. Public Law 110-85. 2007 Sep;121 stat:904-922. Available from: http://www.gpo.gov/fdsys/pkg/PLAW-110publ85/pdf/PLAW-110publ85.pdf
  9. MRCT. Return of results guidance document. Version 1.0. 2015 Mar. Available from: http://mrctcenter.org/files/mrct/files/2015-03-19_mrct_ror_guidance_1.0.pdf
  10. The MRCT Center at Harvard. Return of results toolkit. Version 1.0. 2015 Mar. Available from: http://mrctcenter.org/files/mrct/files/2015-03-19_mrct_ror_toolkit_1.0.pdf
  11. Ciscrp.org. CISCRP trial results summaries c2015 [cited 2015 Aug 29]. Available from: https://www.ciscrp.org/programs-events/trial-results/results-summaries/
  12. Ctep.cancer.gov. CTCAE v4.0 terms with lay terms [cited 2015 Aug 29]. Available from: http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcae_4_with_lay_terms.pdf
  13. Medicines.org.uk. EMC [Cited 2015 Aug 29]. Available from: http://www.medicines.org.uk/emc/
  14. European Commission. Guideline on the readability of the labelling and package leaflet of medicinal products for human use. Revision 1. 2009 Jan. Available from: http://ec.europa.eu/health/files/eudralex/vol-2/c/2009_01_12_readability_guideline_final_en.pdf
  15. Ema.europa.eu. c1995-2015 EMA [cited 2015 Aug 29]. Examples of EPAR and RMP for Plegridy™. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002827/human_med_001782.jsp&mid=WC0b01ac058001d124
  16. Raynor DK, Bryant D. European public assessment report (EPAR) summaries for the public: are they fit for purpose? A user-testing study. BMJ Open. 2013;3(9). Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3780304/
  17. Cancerresearchuk.org. Cited 2015 Aug 29. Note: click on about cancer, clinical trials, type in drug name, tick ‘have results available’ search, select clinical trial and click on trial results + to show lay results. Available from: http://www.cancerresearchuk.org/
  18. Bouder F, Way D, Loefstedt R, Evensen D. Transparency in Europe: a quantitative study. Risk Anal. 2015;35(7):1210–29. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25931009

Search

Articles

Writing for lay audiences
President's Message
Writing for lay audiences: A challenge for scientists
Patient education accessibility
Legislation and the lay audience: Challenges of communicating benefit and risk in the light of new regulations
Medical writing for two audiences – The RMP public summary
Layperson summaries of clinical trial results: Useful resources in the vacuum of regulatory guidance
Package leaflets for medication in the EU: The possibility of integrating patients’ perspectives in a regulated genre?
What do writers need to know about user testing?
Medical journalism: Another way to write about science
Elements of storytelling in medical journalism
A stroll through the medical blogosphere
Writing narrative style literature reviews
News from the EMA
Profile: An interview with Laura Carolina Collada Ali: On the peculiarities of working for independent research organisations
The Webscout
In the Bookstores
Regulatory Writing
Lingua Franca and Beyond
Gained in Translation
English Grammar and Style
Out On Our Own

Member Login

Links

The Write Stuff Archive Contact Instructions for Authors Feature Article Template (Word) Journal Policies

Editoral Board

Editor-in-Chief:

Co-Editor:

Managing Editor

  • Victoria White (Tampa, Florida, USA) Email: MEW@emwa.org
show all +

Associate Editors:

Section Editors:

Ad-hoc Editors:

  • Amy Whereat (SpeaktheSpeech Consulting, Asnieres sur Seine, France)

Editor Emeritus: